Bioline Rx reported $38.8M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Arca Biopharma USD 504.48M 15.86M Mar/2026
Bio Path USD 677K 13K Mar/2026
Bioline Rx USD 38.8M 2.11M Mar/2026
Capricor Therapeutics USD 326.28M 29.66M Mar/2026